Your browser doesn't support javascript.
loading
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vandermeulen, Corinne; Leroux-Roels, Isabel; Vandeleur, James; Staniscia, Tommaso; Girard, Ginette; Ferguson, Murdo; Icardi, Giancarlo; Schwarz, Tino F; Neville, A Munro; Nolan, Terry; Cinquetti, Sandro; Akhund, Tauseefullah; Van Huyneghem, Sofie; Aggravi, Marianna; Kunnel, Barry; de Wergifosse, Bertrand; Domenico, Gabriele Filippo Di; Costantini, Marco; Vir Singh, Puneet; Fragapane, Elena; Lattanzi, Maria; Pellegrini, Michele.
Afiliação
  • Vandermeulen C; Leuven University Vaccinology Centre, Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35, PO 7001, 3000 Leuven, Belgium. Electronic address: corinne.vandermeulen@kuleuven.be.
  • Leroux-Roels I; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium. Electronic address: isabel.lerouxroels@uzgent.be.
  • Vandeleur J; Paratus Clinical Blacktown Clinic, Main Street, Blacktown, NSW 2148, Australia.
  • Staniscia T; Department of Medicine and Aging Sciences, 'G. d'Annunzio' University Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. Electronic address: tommaso.staniscia@unich.it.
  • Girard G; Diex Research, 15 J.-A. Bombardier, Sherbrooke, Québec J1L 0H8, Canada. Electronic address: ggirard@diex.ca.
  • Ferguson M; Colchester Research Group, 68 Robie Street, Truro, Nova Scotia, Canada. Electronic address: mftruroclinics@eastlink.ca.
  • Icardi G; Department of Health Sciences (Dissal), University of Genoa, and Hygiene Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy. Electronic address: icardi@unige.it.
  • Schwarz TF; Klinikum Würzburg Mitte, Standort Juliusspital, Salvatorstr. 7, 97074 Würzburg, Germany. Electronic address: tino.schwarz@kwm-klinikum.de.
  • Neville AM; AusTrials, Level 3, Westside Private Hospital, 32 Morrow St, Taringa, QLD 4068, Australia. Electronic address: munro.neville@austrials.com.au.
  • Nolan T; Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3010, Australia; Murdoch Children's Research Institute, Parkville, Victoria 3052, Australia. Electronic address: t.nolan@unimelb.edu.au.
  • Cinquetti S; Public Health Department, Local Health Unit N. 2 'Marca Trevigiana', Treviso, Veneto Region, Italy. Electronic address: sandro.cinquetti@aulss2.veneto.it.
  • Akhund T; GSK, Clinical Research and Development Centre, Via Fiorentina 1, Siena 53100, Italy. Electronic address: tauseefullah.x.akhund@gsk.com.
  • Van Huyneghem S; GSK, Regional Evidence Generation, Avenue Pascal 2, 4, 6, 1300 Wavre, Belgium. Electronic address: sofie.x.van-huyneghem@gsk.com.
  • Aggravi M; GSK, Technical Development, Via Fiorentina 1, Siena 53100, Italy. Electronic address: marianna.x.aggravi@gsk.com.
  • Kunnel B; GSK, Data Strategy & Management, Global Clinical Operations Development - R&D, Hullenbergweg 83-85, 1101CL Amsterdam, the Netherlands. Electronic address: barry.x.kunnel@gsk.com.
  • de Wergifosse B; GSK, Clinical Laboratory Sciences, Rue de l'Institut, 89, 1330 Rixensart, Belgium. Electronic address: bertrand.d.de-wergifosse@gsk.com.
  • Domenico GFD; GSK, Biostatistics and Statistical Programming, Via Fiorentina 1, Siena 53100, Italy. Electronic address: gabriele-filippo.x.di-domenico@gsk.com.
  • Costantini M; GSK, Biostatistics and Statistical Programming, Via Fiorentina 1, Siena 53100, Italy. Electronic address: marco.x.costantini@gsk.com.
  • Vir Singh P; GSK, Safety Evaluation and Risk Management, Via Fiorentina 1, Siena 53100, Italy. Electronic address: puneetvirsingh.x.puneetvirsingh@gsk.com.
  • Fragapane E; GSK, Clinical Research and Development Centre, Via Fiorentina 1, Siena 53100, Italy. Electronic address: elena.x.fragapane@gsk.com.
  • Lattanzi M; GSK, Clinical Research and Development Centre, Via Fiorentina 1, Siena 53100, Italy. Electronic address: maria.x.lattanzi@gsk.com.
  • Pellegrini M; GSK, Clinical Research and Development Centre, Via Fiorentina 1, Siena 53100, Italy. Electronic address: michele.x.pellegrini@gsk.com.
Vaccine ; 39(45): 6628-6636, 2021 10 29.
Article em En | MEDLINE | ID: mdl-34635373
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Infecções Meningocócicas Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Infecções Meningocócicas Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article